Supersapiens Launches Diabetes Platform in the US

09.01.2024

Supersapiens, backed by our Swiss Diabetes Venture Fund, launches cutting-edge Diabetes platform, empowering users to manage glucose levels. US free beta version invites feedback for continuous improvement.

Supersapiens, backed by our Swiss Diabetes Venture Fund, launches cutting-edge Diabetes platform, empowering users to manage glucose levels. US free beta version invites feedback for continuous improvement.

Similar Articles

04.12.2024

Art Recognition Achieves World’s First in AI-Only Art Authentication

20.11.2024

Apaleo Secures €20M Growth Equity to Accelerate Global Expansion

15.11.2024

Klepsydra Technologies and SYSGO Partner to Advance AI in Aerospace

10.11.2024

BOYDSense Chosen to Pitch at European Innovation Council HealthTech Day

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

Your cookie preferences have been saved.